The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Dr. Fauci Talks COVID-19 with the ACR

Dr. Fauci Talks COVID-19 with the ACR

November 10, 2020 • By Susan Bernstein

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Anthony S. Fauci, MD (NIAID)

Anthony S. Fauci, MD (NIAID)

ACR CONVERGENCE 2020—At the ACR’s fully virtual annual meeting on Saturday, Nov. 7, Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases (NIAID) since 1984, delivered a special lecture on COVID-19, from virology to therapy to vaccine development.

You Might Also Like
  • The ACR Expresses Strong Support for Dr. Anthony Fauci
  • Inaugural ACR Distinguished Global Public Health Award Presented to Dr. Fauci
  • ACR Convergence 2020: COVID-19 Hyper-Inflammation in Kids
Explore This Issue
December 2020
Also By This Author
  • Ohio Rheumatologists Advocate for Step Therapy Reform & More

Novel Coronavirus, Familiar Vectors
When Chinese physicians first reported infections by what appeared to be a novel coronavirus in December 2019, infectious disease experts drew on decades of experience with coronaviruses, including those that cause severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS) and many common colds, said Dr. Fauci.1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“Here we are now with a global pandemic of historic proportions the likes of which we have not seen in the last 102 years. We are now currently close to 50 million cases worldwide. In the United States, we have been hit the hardest of any other country,” he said. As of the first week of November, more than 230,000 deaths from COVID-19 were reported in the U.S., according to the Centers for Disease Control and Prevention (CDC).

Dr. Fauci compared seven-day rolling averages of new infection rates from Jan. 1 to Nov. 4 in the U.S., with a weekly average of 86,300 cases, and the European Union (EU), with a weekly average of 190,700 cases.2 In the U.S., most new infections seen in March and April were in the Northeast, particularly metropolitan New York City, “but we never came back down to a low baseline even as New York cases sharply came down, because other areas of our large country began to have more cases,” he said. “Unfortunately, on Nov. 4, we hit 100,000 cases in a single day. The European Union is doing rather poorly also, with a resurgence of cases mostly related to the cooler weather, which is driving people indoors.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Virology & Transmission
SARS-CoV-2 is a beta coronavirus in the same subgenus as SARS-CoV-1, which caused SARS, and other bat coronaviruses, said Dr. Fauci.3

“It’s an RNA virus and has a rather large genome and multi-structural proteins, the most important of which is the S protein, or spike protein, giving the virus the appearance of a corona or crown. When you look at it under electron microscopy, the receptor-binding domain of the spike binds to the ACE-2 cellular receptor, which is distributed widely in the upper and lower airways,” as well as the gastrointestinal tract, and neurological and cardiovascular systems of the body, he said.

Pages: 1 2 3 4 | Single Page

Filed Under: ACR Convergence, Meeting Reports Tagged With: ACR Convergence 2020, Anthony S. Fauci, COVID-19Issue: December 2020

You Might Also Like:
  • The ACR Expresses Strong Support for Dr. Anthony Fauci
  • Inaugural ACR Distinguished Global Public Health Award Presented to Dr. Fauci
  • ACR Convergence 2020: COVID-19 Hyper-Inflammation in Kids
  • ACR Convergence 2020: Progress Toward COVID-19 Vaccines

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.